- Home
- LAES vs VNDA Comparison
LAES vs VNDA Comparison
Compare LAES & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAES
- VNDA
- Stock Information
- Founded
- LAES 2022
- VNDA 2002
- Country
- LAES Switzerland
- VNDA United States
- Employees
- LAES N/A
- VNDA N/A
- Industry
- LAES Semiconductors
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- LAES Technology
- VNDA Health Care
- Exchange
- LAES Nasdaq
- VNDA Nasdaq
- Market Cap
- LAES 307.1M
- VNDA 257.8M
- IPO Year
- LAES N/A
- VNDA 2006
- Fundamental
- Price
- LAES $3.33
- VNDA $4.43
- Analyst Decision
- LAES Strong Buy
- VNDA Strong Buy
- Analyst Count
- LAES 1
- VNDA 2
- Target Price
- LAES $6.00
- VNDA $16.50
- AVG Volume (30 Days)
- LAES 20.3M
- VNDA 640.7K
- Earning Date
- LAES 03-20-2025
- VNDA 02-13-2025
- Dividend Yield
- LAES N/A
- VNDA N/A
- EPS Growth
- LAES N/A
- VNDA N/A
- EPS
- LAES N/A
- VNDA N/A
- Revenue
- LAES $20,135,000.00
- VNDA $198,772,000.00
- Revenue This Year
- LAES N/A
- VNDA $16.07
- Revenue Next Year
- LAES N/A
- VNDA $24.42
- P/E Ratio
- LAES N/A
- VNDA N/A
- Revenue Growth
- LAES N/A
- VNDA 3.18
- 52 Week Low
- LAES $0.29
- VNDA $3.71
- 52 Week High
- LAES $11.00
- VNDA $6.75
- Technical
- Relative Strength Index (RSI)
- LAES 45.63
- VNDA 44.53
- Support Level
- LAES $3.02
- VNDA $4.34
- Resistance Level
- LAES $3.98
- VNDA $4.65
- Average True Range (ATR)
- LAES 0.47
- VNDA 0.21
- MACD
- LAES -0.03
- VNDA -0.01
- Stochastic Oscillator
- LAES 33.24
- VNDA 36.51
About LAES SEALSQ Corp
SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. Its vaultIC range offers a complete set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.